UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000043152 |
|---|---|
| Receipt number | R000049257 |
| Scientific Title | An analysis of mitochondrial DNA in interstitial pneumonia and lung cancer |
| Date of disclosure of the study information | 2021/01/27 |
| Last modified on | 2021/01/27 15:39:32 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
An analysis of mitochondrial DNA in interstitial pneumonia and lung cancer
Acronym
AMU-mtDNA-STUDY
Scientific Title
An analysis of mitochondrial DNA in interstitial pneumonia and lung cancer
Scientific Title:Acronym
AMU-mtDNA-STUDY
Region
| Japan |
Condition
Condition
Interstitial pneumonia and lung cancer
Classification by specialty
| Pneumology |
Classification by malignancy
Malignancy
Genomic information
YES
Objectives
Narrative objectives1
To study mitochondrial DNA expression in patients with interstitial pneumonia and/or with lung cancer.
Basic objectives2
Bio-availability
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
To analyze plasma levels of mitochondrial DNA
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients with advanced lung cancer.
Patients with interstitial pneumonia.
Key exclusion criteria
None
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | Shunsuke |
| Middle name | |
| Last name | Okumura |
Organization
Asahikawa Medical University Hospital
Division name
Respiratory Center
Zip code
0788510
Address
2-1-1-1 Midorigaoka-Higashi, Asahikawa, Hokkaido, Japan
TEL
0166693290
okumura-@asahikawa-med.ac.jp
Public contact
Name of contact person
| 1st name | Shunsuke |
| Middle name | |
| Last name | Okumura |
Organization
Asahikawa Medical University Hospital
Division name
Respiratory Center
Zip code
0788510
Address
2-1-1-1 Midorigaoka-Higashi, Asahikawa, Hokkaido, Japan
TEL
0166693290
Homepage URL
okumura-@asahikawa-med.ac.jp
Sponsor or person
Institute
Asahikawa Medical University
Institute
Department
Personal name
Funding Source
Organization
Self funding
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Asahikawa Medical University
Address
2-1-1-1 Midorigaoka-Higashi, Asahikawa, Hokkaido, Japan
Tel
0166693290
okumura-@asahikawa-med.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 01 | Month | 27 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2019 | Year | 05 | Month | 27 | Day |
Date of IRB
| 2019 | Year | 05 | Month | 31 | Day |
Anticipated trial start date
| 2019 | Year | 05 | Month | 31 | Day |
Last follow-up date
| 2024 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
In this observational study, we will observe risk factors, results of clinical tests, other intervention in the patients.
Management information
Registered date
| 2021 | Year | 01 | Month | 27 | Day |
Last modified on
| 2021 | Year | 01 | Month | 27 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049257
